New PET tracer for brain imaging tested in humans for first time
NCT ID NCT03347331
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-phase study tested a new radioactive tracer called [18F]F13640 in 20 healthy volunteers. The tracer is designed to attach to specific receptors in the brain and be seen on a PET scan. The goal was to validate the imaging method and check how reproducible the results are, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- [18F]F13640 (a radioactive tracer for PET scans)
- What this could lead to
- If successful, this could provide a new way to image brain receptors, potentially aiding research into neurological conditions.
- What could go wrong
- This is a very early, small study in healthy people only. It is designed to test the imaging method, not to treat any disease, so direct patient benefits are far off.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospices Civils de Lyon
Bron, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Radioactive tracer reveals the Body's journey of an experimental drug
- Can music lessons rewire Teens' social media habits?
- Can a Finger-Prick replace the lab draw? a device puts accuracy to the test
- Avocado at breakfast: a secret weapon for blood sugar and fullness?
- Sound waves as medicine: ultrasound may tame inflammation without drugs
- Broader pneumonia shield: new vaccine tested in children